Novartis sells stake in joint venture to GSK for $13 bln

Swiss pharmaceuticals giant Novartis announced on March 27 it will sell its stake in its consumer healthcare joint venture to Britain's GlaxoSmithKline for $13 billion (10.4 billion euros).